A post-marketing clinical study of rebamipide to investigate the gastric ulcer healing effect of continued dosing following Helicobacter pylori eradication therapy
Phase of Trial: Phase IV
Latest Information Update: 13 May 2016
At a glance
- Drugs Rebamipide (Primary)
- Indications Gastric ulcer
- Focus Adverse reactions; Therapeutic Use
- Sponsors Otsuka Pharmaceutical
- 25 May 2007 Status changed from in progress to completed.
- 05 Nov 2005 New trial record.